GHO to buy out Ardian’s stake in Envision Pharma

Paris-based Ardian and London-based GHO jointly acquired Envision in July 2016 from the Halifax Group, with the former assuming a majority stake.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this